Key points are not available for this paper at this time.
Functional neuroimaging has developed a fundamental ground for understanding the physical basis of the brain. Recent studies have extracted invaluable information from the underlying substrate of the brain. However, cognitive deficiency has insufficiently been assessed by researchers in multiple sclerosis (MS). Therefore, extracting the brain network differences among relapsing-remitting MS (RRMS) patients and healthy controls as biomarkers of cognitive task functional magnetic resonance imaging (fMRI) data and evaluating such biomarkers using machine learning were the aims of this study.
Azarmi et al. (Mon,) studied this question.